Abstract: Despite being one of the most common congenital defects in boys, the etiology of hypospadias remains largely unknown. In this study we evaluated a spectrum of potential risk factors for hypospadias in which we focused on both paternal and maternal factors and chromosomal aberrations. Cases were selected from the Genetic Clinic, Medical Research Institute, University of Alexandria. A total of 176 cases with hypospadias were included in this study, and a matching control group of normal 300 boys for the association study. All cases were subjected to detailed family, pregnancy, genetic histories, clinical examination, and pedigree study. Chromosome analysis was performed using peripheral blood lymphocyte cultures by trypsin G-banding technique. Hormonal assays, abdominal and pelvic ultrasound were carried out according to case presentation. Both parents of cases and the control group completed written questionnaires. Abnormal karyotyes were detected in 23 cases (13.07%) associated with other anomalies, sex chromosome abnormalities were present in 69.56% and autosomal aberrations in 30.43%. Patients with chromosomal abnormalities were excluded from the association study. Logistic regression analysis was used to assess the independent contribution of different factors to the risk of hypospadias. Our data did not support an association with increased parental age. The most profound result was the increased risk of hypospadias for boys with positive family history (n=23; OR=26.36; 95% CI: 5.90-164.23). Strong indications for an increased risk of hypospadias were also found with low birth weight (n=45; OR=13.47; 95% CI=6.09-30.70), preterm birth (n=6; OR=12.20; 95% CI=1.45-271.47), twin or triplet pregnancy (n=4; OR=8.03; 95% CI=0. 84-190.23), and when mothers had preeclampsia (n=16; OR=11.56; 95% CI=3.11-50.77). Associations with pregnancy achieved with fertility treatment, and mother used iron supplements were also found. In conclusion, routine karyotype screening permits the diagnosis of chromosomal anomalies especially in those with the most severe forms of hypospadias and additional anomalies. Several risk factors have been identified for hypospadias which support the idea that genetic predisposition, placental insufficiency, and substances that interfere with natural hormones before conception or during fetal development play a role in the etiology of hypospadias.
INTRODUCTION
Hypospadias is one of the most common developmental disorder of the urogenital tract, with an estimated prevalence of 3 to 8 per 1000 male livebirths [1, 2] . Defined as an atypical urethral opening anywhere along the shaft of the penis, scrotum, or perineum. Hypospadias is often associated with a deficient prepuce and chordee. The malformation results from incomplete fusion of the urethral folds which usually occurs between 7th and 14th weeks of gestation [3] . Hypospadias usually occurs as an isolated defect, but can be part of a recognized syndrome or associated with other genital anomalies [4] .
Known etiological factors are the same as those of intersex disorders and include complex genetic syndromes, and chromosomal abnormalities Among single etiological factors chromosomal abnormalities are found in 5% to 12% of cases [5, 6] .
The etiology of nonsyndromic hypospadias is unknown, and is believed to be multifactorial . An etiological role for genetic and environmental factors has been postulated since ethnic as well as geographic differences in incidence exist and the incidence is increasing in many countries [6] . Recent studies have implicated factors such as familial inheritance, low birth weight, advanced maternal age, paternal subfertility, and environmental exposure in the form of endocrine disruption chemicals in the pathogenesis of hypospadias [4, 7] .
Endocrine disruptors are exogenous substances that behave similarly to biologic hormones and is the most likely explanation for the worldwide increase in incidence in the last three decades. They interfere with the physiologic functions of the endogenous hormones by affecting the release, binding, or metabolism of the endogenous hormones,…, etc. An example of such is the non-steroidal estrogen diethylstilbestrol (DES) [7] . [7] .
Hormonal assays and, abdominal and pelvic ultrasound were carried out according to case presentation.
Data collection:
Both parents of cases and control group were asked to fill out the same written questionnares. Subsequently, all potential risk factors were simultaneously included in logistic regression models in order to assess their independent contribution to the risk of hypospadias.
RESULTS
The age of the studied cases ranged from 6 days to 15 years. Chromosome abnormalities were identified in 23 of the 176 patients with hypospadias (13.07%), they were detected only in cases with other associated anomalies. Most of the abnormalities were found in severe type of hypospadias (7.95%) ( Associations with increased patterned age pregnancy achieved with fertility treatment, and mother used iron supplements were also found. [9, 10] .
The severity of hypospadias in our study was 8.52% glandular or coronal; 60.23% penile; and 31.25% perineal or scrotal defects. This is different from that recorded in other studies where 68.7% were distal; 24.8% penile, and 6.3% perineal [9] [10] [11] . The discrepancy is most propably due to the selection criteria of the sample used as mild defects are not usually referred for genetic evaluation. published. Moreno-Garcia and Miranda [12] identified chromosomal anomalies in 7% of males with hypospadias, while Yamaguchi et al., [5] detected them in 11.11%. McAleer and Kaplan [13] concluded that those with the most severe forms of hypospadias, particularly at the perineal meatus location, have a higher likelihood of intersex or sex chromosome abnormality, a finding which is present in our study. Most reports involve small series of patients with a small number of abnormal karyotypes, and so they may not reflect the true incidence of chromosomal abnormalities. When cryptorchidism is associated with hypospadias, the incidence of chromosomal anomalies is higher than in patients with only cryptorchidism or hypospadias [13] .
Although hypospadias is common, risk factors for this birth defect are relatively poorly defined. Familial aggregation is well recognized [14] , but other risk factors are more controversial [15] .
In the present study we did not found a positive association between advanced maternal age and hypospadias. Muliple studies investigating hypospadias did not report an association with maternal age [16, 17] . However, Fisch et al., [18] reported a 50% higher risk of hypospadias among women >35 years of age, compared with women <20 years of age. Other studies reported similar results and demonstrated a linear relationship between maternal age and hypospadias risk, with risk nearby doubling by time women were >40 years of age [1, 19] . It is not known why maternal age may be a risk factor for hypospadias. They concluded that older women are at higher risk of having children with genetic defects.
It is therefore plausible that the risk is mediated via underlying genetic defects associated with aging. Some authers have suggested that subfertility is a potential mechanism linking hypospadias with maternal age, because subfertile women often are older at the time of first conception [3] . Increased paternal age did not appear to contribute to increased risk of hypospadias in the present study. This is in agreement with previous studies which did not report any association between paternal age and hypospadias [17, 19] . [20] . However, exposure to environmental contaminants is now being considered in familial clusters because of the high probability of shared exposures among first-degree relatives [21] . The overall risk for a brother of an affected infant to also have hypospadias was 9.6%. [3, 22] These sibs occurrence risks are compatible with a multifactorial mode of inheritance for hypospadias.
Consistent with previous literature [10, 11, 23] , we found an increased hypospadias [24] . An increased risk for hypospadias among twins has been described by Kallen et al. [22] Concordance among twins of the same sex was 18% for both mild and severe forms, with increased risk evident in both monozygotic and dizygotic twins. When monozygotic twins discordant for hypospadias were evaluated, the twin with the lowest birth weight had hypospadias suggesting a gene-environment interaction [25] .
Our results also point towards an association between fertility treatment and
hypospadias. An increased risk of secondand third degree hypospadias was found among infants delivered to women who took progestins during early pregnancy to help them become pregnant or to prevent pregnancy complications or loss, the odds ratios suggested a least 2-fold increased risk [26, 27] . In previous studies, an increased occurrence of hypospadias was reported following IVF and ICSI treatments [28, 29] .
One possible explanation is that hormones administered as part of fertility treatment production or its conversion to DHT [26] .
An increased risk of hypospadias was found in the present study when mothers used iron supplements immediately prior to conception and/or during the first trimester of pregnancy. This association was previously reported in several studies [10, 30] .
Iron deficiency anemia in early pregnancy has been associated with preterm delivery, possibly due to long-term hypoxia and oxidative stress [31] . Furthermore, it has been suggested that iron supplementation in mothers who are not iron deficient may cause toxic reactions or increase blood viscosity, which subsequently impairs placental blood flow [32] .
Like Akre et al., [33] and Chong et al., [23] maternal preeclampsia was found to be significantly associated with hypospadias in our study. Whether and how maternal preeclampsia, a late gestational event,
relates to the development of the external genitalia remains unclear [34] . Akre et al., [35] concluded that this association was compatible with a role for placental insufficiency in the etiology of hypospadias. 
